Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00667082 | NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma | completed | Phase 1 | 22 | CelgeneINDUSTRY | 1 | Nov 22, 2017 | clinicaltrials |
| NCT01430052 | Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Osaka Medical Center for Cancer and Cardiovascular DiseasesOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT02272738 | A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer | completed | Phase 1 | 54 | Osaka Medical Center for Cancer and Cardiovascular DiseasesOTHER | 1 | Nov 21, 2017 | clinicaltrials |
| NCT00666978 | Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking | completed | Phase 4 | 540 | Lisa Sanderson Cox, PhDOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT01392027 | Biospecimens for Identification of Diseases of the Pancreas.(SPORE-PANC) | completed | N/A | 712 | University of MichiganOTHER | 1 | Nov 8, 2017 | clinicaltrials |
| NCT00383760 | Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Oct 20, 2017 | clinicaltrials |
| NCT03302637 | Oral Microbiome and Pancreatic Cancer | completed | — | 732 | NYU Langone HealthOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT00584363 | Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection(SPORE) | completed | — | 731 | University of Alabama at BirminghamOTHER | 1 | Oct 5, 2017 | clinicaltrials |
| NCT02241187 | Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection | completed | N/A | 2 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 27, 2017 | clinicaltrials |
| NCT02486497 | Adjuvant Gemcitabine Versus 5-FU/Leucovorin Based on hENT1 Immunostaining | completed | N/A | 40 | Seoul National University HospitalOTHER | 1 | Sep 25, 2017 | clinicaltrials |
| NCT01897415 | Autologous Redirected RNA Meso CAR T Cells for Pancreatic Cancer | completed | Phase 1 | 16 | University of PennsylvaniaOTHER | 1 | Sep 19, 2017 | clinicaltrials |
| NCT00900016 | Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery | completed | — | 37 | Fox Chase Cancer CenterOTHER | 1 | Sep 11, 2017 | clinicaltrials |
| NCT00763516 | Proton Radiation for Resectable Carcinoma of the Pancreas(PC02) | completed | N/A | 8 | University of FloridaOTHER | 1 | Sep 6, 2017 | clinicaltrials |
| NCT01553019 | Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer(PC03) | completed | Phase 2 | 2 | University of FloridaOTHER | 1 | Sep 6, 2017 | clinicaltrials |
| NCT01150630 | Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer(PACT-15) | completed | Phase 2 | 98 | IRCCS San RaffaeleOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT01730222 | A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma(PACT-19) | completed | Phase 1 / Phase 2 | 137 | IRCCS San RaffaeleOTHER | 1 | Sep 1, 2017 | clinicaltrials |
| NCT01523457 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer(FOLFIRINOX) | completed | Phase 2 | 75 | Yale UniversityOTHER | 1 | Aug 30, 2017 | clinicaltrials |
| NCT01770405 | Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract(US-nCLE) | completed | — | 40 | Mauna Kea TechnologiesINDUSTRY | 1 | Aug 29, 2017 | clinicaltrials |
| NCT00685763 | Proton Therapy for Unresectable Cancer (CA) of Pancreas(PC01) | completed | N/A | 13 | University of FloridaOTHER | 1 | Aug 24, 2017 | clinicaltrials |
| NCT01783171 | Dinaciclib and Akt Inhibitor MK2206 in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 2 | Aug 22, 2017 | clinicaltrials |
| NCT00288093 | 3-AP and Radiation Therapy in Treating Patients With Stage III Pancreatic Cancer That Cannot Be Removed By Surgery | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Aug 18, 2017 | clinicaltrials |
| NCT01764477 | Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma | completed | Phase 1 | 20 | Prism Pharma Co., Ltd.INDUSTRY | 1 | Aug 17, 2017 | clinicaltrials |
| NCT01383538 | FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma | completed | Phase 1 | 15 | Andrew KoOTHER | 1 | Aug 8, 2017 | clinicaltrials |
| NCT01195415 | Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Aug 7, 2017 | clinicaltrials |
| NCT01040000 | QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer | completed | Phase 1 / Phase 2 | 94 | Precision Biologics, IncINDUSTRY | 1 | Aug 4, 2017 | clinicaltrials |
| NCT01809028 | Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions | completed | N/A | 62 | AdventHealthOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT01815606 | Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm | completed | N/A | 51 | AdventHealthOTHER | 1 | Aug 3, 2017 | clinicaltrials |
| NCT01191684 | Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer | completed | Phase 1 | 12 | City of Hope Medical CenterOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT01303029 | Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer(GECA) | completed | Phase 2 | 120 | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)OTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT02080650 | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | completed | N/A | 62 | Duke UniversityOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00920023 | Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI) | completed | Phase 4 | 35 | Massachusetts General HospitalOTHER | 1 | Jul 25, 2017 | clinicaltrials |
| NCT02035072 | Phase II Study of Hypofractionated Radio-chemotherapy With Gemcitabine Plus Oxaliplatin for Unresectable Nonmetastatic Locally Advanced Pancreatic Cancer. | completed | Phase 2 | 40 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT00609336 | Perioperative Therapy for Resectable Pancreatic Cancer | completed | Phase 2 | 35 | University of WashingtonOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT01016483 | Trial of Gemcitabine With or Without MSC1936369B in Pancreatic Cancer | completed | Phase 1 / Phase 2 | 141 | EMD SeronoINDUSTRY | 2 | Jul 13, 2017 | clinicaltrials |
| NCT01236053 | Cancer in Patients With Gabapentin (GPRD) | completed | — | 2,323,608 | GlaxoSmithKlineINDUSTRY | 0 | Jul 6, 2017 | clinicaltrials |
| NCT01209962 | A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response | completed | — | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 5, 2017 | clinicaltrials |
| NCT00987766 | Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer | completed | Phase 1 | 28 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT02117258 | Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma(ZIPANG) | completed | Phase 2 | 167 | Zeria PharmaceuticalINDUSTRY | 3 | Jul 2, 2017 | clinicaltrials |
| NCT02465892 | Pillars4Life Trial(Pillars4Life) | completed | N/A | 284 | Duke UniversityOTHER | 1 | Jul 2, 2017 | clinicaltrials |
| NCT03200821 | An Open Label Study to Evaluate G17DT Compared to Gemcitabine | completed | Phase 3 | 103 | Cancer Advances Inc.INDUSTRY | 0 | Jun 27, 2017 | clinicaltrials |
| NCT01794676 | Genetic Evaluation of Families With Endocrine Cancers(MEN1) | completed | — | 9 | Jersey Shore University Medical CenterOTHER | 1 | Jun 16, 2017 | clinicaltrials |
| NCT01273805 | Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer | completed | Phase 2 | 20 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 14, 2017 | clinicaltrials |
| NCT01646697 | Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery | completed | N/A | 90 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT00424827 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | completed | Phase 2 | 11 | University of Massachusetts, WorcesterOTHER | 0 | Jun 1, 2017 | clinicaltrials |
| NCT00376987 | Zinc Supplements in Lowering Cadmium Levels in Smokers | completed | Phase 2 | 61 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00489515 | Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | completed | — | 115 | Wake Forest University Health SciencesOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT00534001 | Bupropion in Helping Adults Stop Smoking | completed | Phase 2 | 95 | Roswell Park Cancer InstituteOTHER | 1 | May 30, 2017 | clinicaltrials |
| NCT01138124 | Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD) | completed | — | 54,202 | GlaxoSmithKlineINDUSTRY | 0 | May 30, 2017 | clinicaltrials |
| NCT00654160 | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer | completed | Phase 1 | 7 | Mayo ClinicOTHER | 1 | May 25, 2017 | clinicaltrials |
| NCT00836992 | Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer | completed | — | 144 | Mayo ClinicOTHER | 1 | May 24, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Nov 22, 2017source: clinicaltrials